Artificial intelligence (AI) has long been heralded as a game-changer for the pharmaceutical industry, so why are there so few drugs on the market today that resulted from AI?
Webcasts
10 February 2021
In the last five years – since a wide coalition of stakeholders set out and endorsed the application of FAIR principles to research – the principles of findability, accessibility, interoperability, and reusability have become widely recognised and accepted.
10 November 2020
Now available on demand: Join Ansys and Intel to gain insight into how you can optimise your hardware and software deployments for best performance
21 October 2020
Unstructured scientific data is one of the biggest strategic risks to the pharmaceutical industry today
28 September 2020
AI technologies being developed today will lead to new capabilities tomorrow and enable new business applications the day after.
Latest issue
Gemma Church examines how simulation and modelling aid the increasingly diverse renewable energy field
Scientists have implemented automation and LIMS software to help pivot laboratory operations and provide services to better understand and prevent the spread of Covid-19
Sophia Ktori considers how software integration helps ensure scientists work efficiently in the laboratory
A team of international scientists, including Nasa researchers, are using deep learning to map trees and bushes in the drylands of West Africa and the southern Sahara desert
